Display options
Cite
Roesler R, Reolon GK, Maurmann N, et al. A phosphodiesterase 4-controlled switch between memory extinction and strengthening in the hippocampus. Front Behav Neurosci. 2014;8:91doi: 10.3389/fnbeh.2014.00091.
Roesler, R., Reolon, G. K., Maurmann, N., Schwartsmann, G., Schröder, N., Amaral, O. B., Valvassori, S., & Quevedo, J. (2014). A phosphodiesterase 4-controlled switch between memory extinction and strengthening in the hippocampus. Frontiers in behavioral neuroscience, 891. https://doi.org/10.3389/fnbeh.2014.00091
Roesler, Rafael, et al. "A phosphodiesterase 4-controlled switch between memory extinction and strengthening in the hippocampus." Frontiers in behavioral neuroscience vol. 8 (2014): 91. doi: https://doi.org/10.3389/fnbeh.2014.00091
Roesler R, Reolon GK, Maurmann N, Schwartsmann G, Schröder N, Amaral OB, Valvassori S, Quevedo J. A phosphodiesterase 4-controlled switch between memory extinction and strengthening in the hippocampus. Front Behav Neurosci. 2014 Mar 17;8:91. doi: 10.3389/fnbeh.2014.00091. eCollection 2014. PMID: 24672454; PMCID: PMC3955942.
Copy Download .nbib Format: NLM
Share it on

Front Behav Neurosci. 2014 Mar 17;8:91. doi: 10.3389/fnbeh.2014.00091. eCollection 2014.

A phosphodiesterase 4-controlled switch between memory extinction and strengthening in the hippocampus.

Frontiers in behavioral neuroscience

Rafael Roesler, Gustavo K Reolon, Natasha Maurmann, Gilberto Schwartsmann, Nadja Schröder, Olavo B Amaral, Samira Valvassori, João Quevedo

Affiliations

  1. Laboratory of Neuropharmacology and Neural Tumor Biology, Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul Porto Alegre, Brazil ; Cancer Research Laboratory, University Hospital Research Center (CPE-HCPA), Federal University of Rio Grande do Sul Porto Alegre, Brazil ; National Institute for Translational Medicine (INCT-TM) Porto Alegre, Brazil.
  2. Cancer Research Laboratory, University Hospital Research Center (CPE-HCPA), Federal University of Rio Grande do Sul Porto Alegre, Brazil ; National Institute for Translational Medicine (INCT-TM) Porto Alegre, Brazil ; Department of Internal Medicine, School of Medicine, Federal University of Rio Grande do Sul Porto Alegre, Brazil.
  3. National Institute for Translational Medicine (INCT-TM) Porto Alegre, Brazil ; Neurobiology and Developmental Biology Laboratory, Faculty of Biosciences, Pontifical Catholic University Porto Alegre, Brazil.
  4. Leopoldo de Meis Institute of Medical Biochemistry, Federal University of Rio de Janeiro Rio de Janeiro, Brazil.
  5. National Institute for Translational Medicine (INCT-TM) Porto Alegre, Brazil ; Laboratory of Neurosciences, Graduate Program in Health Sciences, Academic Unit of Health Sciences, University of Southern Santa Catarina (UNESC) Criciúma, Brazil.
  6. National Institute for Translational Medicine (INCT-TM) Porto Alegre, Brazil ; Laboratory of Neurosciences, Graduate Program in Health Sciences, Academic Unit of Health Sciences, University of Southern Santa Catarina (UNESC) Criciúma, Brazil ; Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School at Houston Houston, TX, USA.

PMID: 24672454 PMCID: PMC3955942 DOI: 10.3389/fnbeh.2014.00091

Abstract

Established fear-related memories can undergo phenomena such as extinction or reconsolidation when recalled. Extinction probably involves the creation of a new, competing memory trace that decreases fear expression, whereas reconsolidation can mediate memory maintenance, updating, or strengthening. The factors determining whether retrieval will initiate extinction, reconsolidation, or neither of these two processes include training intensity, duration of the retrieval session, and age of the memory. However, previous studies have not shown that the same behavioral protocol can be used to induce either extinction or reconsolidation and strengthening, depending on the pharmacological intervention used. Here we show that, within an experiment that leads to extinction in control rats, memory can be strengthened if rolipram, a selective inhibitor of phosphodiesterase type 4 (PDE4), is administered into the dorsal hippocampus immediately after retrieval. The memory-enhancing effect of rolipram lasted for at least 1 week, was blocked by the protein synthesis inhibitor anisomycin, and did not occur when drug administration was not paired with retrieval. These findings indicate that the behavioral outcome of memory retrieval can be pharmacologically switched from extinction to strengthening. The cAMP/protein kinase A (PKA) signaling pathway might be a crucial mechanism determining the fate of memories after recall.

Keywords: extinction; fear memory; hippocampus; inhibitory avoidance; phosphodiesterase 4; reconsolidation; rolipram

References

  1. Neuroreport. 2006 Jun 26;17(9):935-9 - PubMed
  2. Front Behav Neurosci. 2013 Sep 09;7:118 - PubMed
  3. Neuropsychopharmacology. 2008 Jan;33(1):56-72 - PubMed
  4. Neuroscience. 2013 Aug 6;244:42-8 - PubMed
  5. Neuropharmacology. 2008 Oct;55(5):788-92 - PubMed
  6. Neurobiol Learn Mem. 2013 Sep;104:25-31 - PubMed
  7. Hippocampus. 2008;18(6):584-601 - PubMed
  8. Pharmacol Biochem Behav. 2011 Aug;99(2):155-63 - PubMed
  9. Neuron. 2003 Jun 19;38(6):863-9 - PubMed
  10. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12251-4 - PubMed
  11. PLoS One. 2011;6(8):e23113 - PubMed
  12. J Exp Psychol Anim Behav Process. 1979 Oct;5(4):368-78 - PubMed
  13. Front Behav Neurosci. 2010 Nov 11;4:168 - PubMed
  14. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10518-22 - PubMed
  15. J Neurosci. 2006 Sep 27;26(39):10051-6 - PubMed
  16. Nat Neurosci. 2014 Jan;17(1):65-72 - PubMed
  17. J Neurosci. 2009 Jan 14;29(2):402-13 - PubMed
  18. Behav Pharmacol. 1997 Aug;8(4):331-8 - PubMed
  19. Neurobiol Learn Mem. 2012 Jan;97(1):105-12 - PubMed
  20. Nat Rev Drug Discov. 2003 Apr;2(4):267-77 - PubMed
  21. Behav Brain Res. 2004 Oct 5;154(2):339-43 - PubMed
  22. Nat Rev Neurosci. 2000 Dec;1(3):212-3 - PubMed
  23. J Clin Invest. 2004 Dec;114(11):1624-34 - PubMed
  24. Learn Mem. 1999 Nov-Dec;6(6):600-7 - PubMed
  25. J Neurosci. 2011 Feb 2;31(5):1635-43 - PubMed
  26. Nat Neurosci. 2008 Nov;11(11):1264-6 - PubMed
  27. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15020-5 - PubMed
  28. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5280-5 - PubMed
  29. Learn Mem. 2000 Mar-Apr;7(2):73-84 - PubMed
  30. J Neurosci. 2004 May 19;24(20):4787-95 - PubMed
  31. Science. 2003 Aug 22;301(5636):1102-4 - PubMed
  32. Neuropharmacology. 2006 Aug;51(2):350-7 - PubMed
  33. Neurobiol Learn Mem. 1998 Mar;69(2):87-91 - PubMed
  34. Science. 2000 Jan 14;287(5451):248-51 - PubMed
  35. Learn Mem. 2012 Sep 19;19(10):495-8 - PubMed
  36. Behav Brain Res. 2000 Jul;112(1-2):99-105 - PubMed
  37. Nature. 2000 Aug 17;406(6797):722-6 - PubMed
  38. Curr Biol. 2013 Sep 9;23(17):R746-50 - PubMed
  39. Front Behav Neurosci. 2011 Mar 07;5:12 - PubMed
  40. J Neural Transm (Vienna). 2013 Nov;120(11):1525-31 - PubMed
  41. Neuroscience. 2008 Jul 17;154(4):1648-55 - PubMed
  42. Nat Neurosci. 2006 Feb;9(2):167-9 - PubMed
  43. Nature. 2008 Jul 31;454(7204):600-6 - PubMed
  44. Neuroscience. 2009 Jun 2;160(4):711-5 - PubMed
  45. Peptides. 2009 Jun;30(6):1192-6 - PubMed
  46. Biol Psychiatry. 2007 Jul 1;62(1):33-9 - PubMed
  47. Cell. 1997 Mar 7;88(5):615-26 - PubMed
  48. Physiol Behav. 1977 Jan;18(1):95-9 - PubMed

Publication Types